BIVI - הערכת שווי הפעילות בספרים BioVie Inc

BioVie Inc. (BIVI) develops proprietary treatments for metabolic liver pathologies and Alzheimer's disease, while its financial stability depends on clinical trial results as operating cash flow has not yet been established. This price chart illustrates the asset's dynamics, with a metric of 0.01. The company currently relies on investment capital to continue trials of cirrhosis drugs in the absence of stable profit sources.

Since BioVie Inc. (BIVI) focuses on costly clinical trials without current revenue, the issuer's financial stability depends critically on external financing. By analyzing the dynamics of the company's net assets, an investor can see the actual remaining capital minus all liabilities, which allows for an assessment of the internal resources available to complete tests and avoid a value trap should this fundamental indicator stagnate.